48 related articles for article (PubMed ID: 9930861)
21. Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.
Gundlach BR; Lewis MG; Sopper S; Schnell T; Sodroski J; Stahl-Hennig C; Uberla K
J Virol; 2000 Apr; 74(8):3537-42. PubMed ID: 10729127
[TBL] [Abstract][Full Text] [Related]
22. Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques.
Rosenwirth B; ten Haaft P; Bogers WM; Nieuwenhuis IG; Niphuis H; Kuhn EM; Bischofberger N; Heeney JL; Uberla K
J Virol; 2000 Feb; 74(4):1704-11. PubMed ID: 10644340
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus.
Dittmer U; Race B; Hasenkrug KJ
J Virol; 1999 Oct; 73(10):8435-40. PubMed ID: 10482595
[TBL] [Abstract][Full Text] [Related]
24. Attenuated retrovirus vaccines and AIDS.
Shearer GM; Lucey DR; Clerici M
Science; 1995 Nov; 270(5239):1219; author reply 1220-2. PubMed ID: 7502053
[No Abstract] [Full Text] [Related]
25. Attenuated retrovirus vaccines and AIDS.
Van Rompay KK; Spinner A; Otsyula M; McChesney MB; Marthas ML
Science; 1995 Nov; 270(5239):1218-9; author reply 1220-2. PubMed ID: 7502051
[No Abstract] [Full Text] [Related]
26. Live HIV vaccines--how safe?
Dittmer U; Stahl-Hennig C; Hunsmann G
Nat Med; 1997 Aug; 3(8):816. PubMed ID: 9256262
[No Abstract] [Full Text] [Related]
27. Live attenuated AIDS vaccines: hazards and hopes.
Johnson RP
Nat Med; 1999 Feb; 5(2):154-5. PubMed ID: 9930861
[No Abstract] [Full Text] [Related]
28. HIV vaccine design: insights from live attenuated SIV vaccines.
Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
[TBL] [Abstract][Full Text] [Related]
29. Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine.
Das AT; Zhou X; Vink M; Klaver B; Berkhout B
Expert Rev Vaccines; 2002 Oct; 1(3):293-301. PubMed ID: 12901570
[TBL] [Abstract][Full Text] [Related]
30. Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine.
Berkhout B; Verhoef K; Marzio G; Klaver B; Vink M; Zhou X; Das AT
J Neurovirol; 2002 Dec; 8 Suppl 2():134-7. PubMed ID: 12491165
[TBL] [Abstract][Full Text] [Related]
31. 1999: a time to re-evaluate AIDS vaccine strategies.
Ruprecht RM; Hofmann-Lehmann R; Rasmussen RA; Vlasak J; Xu W
J Hum Virol; 2000; 3(2):88-93. PubMed ID: 10850895
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
